BHVN ▲ +1.0% - Biohaven Ltd. $BHVN - Biohaven Drives New Research in Graves' Disease: Phase 3 Pivotal Trial with BHV-1300 Underway and Three Scientific Posters at the 2026 American Thyroid Association Annual (ATA) Meeting 05-NOV-2026 07:31 AM ET